DOCSLIB.ORG

Download ADANI X-Ray Medical Imaging Systems Brochurepdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Download ADANI X-Ray Medical Imaging Systems Brochurepdf MAMMOGRAPHY CHEST RADIOGRAPHY GENERAL RADIOGRAPHY & FLUOROSCOPY 0505-MA28022020 MOBILE CLINICS RADIOTHERAPY FORENSICS www.adanisystems.com [email protected] CT With continual development of our products ADANI reserves the right to make changes to the design and specifications at any moment and without notice. www.adanisystems.com MAMMOGRAPHY 2 MAMMOSCAN 3 FULL FIELD DIGITAL MAMMOGRAPHY SYSTEM џ High definition imaging 4096 x 5555 pixels џ Fully automatic exposure control (AEC) џ Scanning time of 6 seconds џ No grid necessary џ Low-dose examinations FDA APPROVED UAB “Diodas” Švyturio g. 2, LT-48423 Kaunas, Lithuania Tel: +37061259134 E-mail: [email protected] Optional biopsy attachment www.adanisystems.com FULL-FIELD DIGITAL TOMOSYNTHESIS MAMMOGRAPHY SYSTEM 4 MAMMOEXPERT 5 THE NEW LEVEL OF CONFIDENCE IN BREAST CANCER DETECTION џ Sharp, detailed and noiseless image with exceptional diagnostic value џ High-resolution detailed 3D image with fewer artifacts џ Fast and error-free diagnostic -21,8 +21,8 -7 procedures џ Significantly lower patient dose +7 џ Full range of advanced diagnostic methods -180 +165 Optimal movements for best diagnostics www.adanisystems.com CHEST RADIOGRAPHY 6 PULMOSCAN 7 X-RAY CHEST SCREENING SYSTEM џ Image quality of 2560 x 2560 pixels џ Fully digital system џ High frequency generator џ Available as: solid cabin construction or open format UAB “Diodas” Švyturio g. 2, LT-48423 Kaunas, Lithuania Tel: +37061259134 E-mail: [email protected] AI cad system on request www.adanisystems.com MOBILE CLINICS 8 MAMMOEXPRESS / PULMOEXPRESS 9 MOBILE BREAST AND CHEST SCREENING UNITS џ The estimated processing of the units is 30+ patients per day џ May be used in any climatic conditions and provide high level comfort both for patients and medical staff џ May be operated both independently, and in cooperation with remote medical facilities џ Unbeatable compactness and robust design implemented џ Quick investment return due to cost effectiveness UAB “Diodas” Švyturio g. 2, LT-48423 Kaunas, Lithuania Tel: +37061259134 E-mail: [email protected] Customized mobile clinics www.adanisystems.com MOBILE CLINICS 10 SCREENEXPRESS reproductive health 11 VEHICLE-BASED MOBILE MULTIMODAL DIAGNOSTIC UNIT 1 Digital mammography room 2 Laboratory diagnostics room 3 Ultrasound diagnostics room 4 Gynecological and urological examination room 1 2 3 4 www.adanisystems.com GENERAL RADIOGRAPHY & FLUOROSCOPY 12 UNIEXPERT 2 PLUS, 3 PLUS 13 RADIOGRAPHY & FLUOROSCOPY SYSTEMS: DIGITAL OR CONVENTIONAL џ Analog, CR, DR systems џ Motorized tilting table and wallstand џ Elevating float-top table or fixed height table џ Available as ceiling tube crane or floor stand џ High-frequency generator џ Touch-screen control џ Automatic collimator UAB “Diodas” Švyturio g. 2, LT-48423 Kaunas, Lithuania Tel: +37061259134 E-mail: [email protected] Cost-effective solutions www.adanisystems.com GENERAL RADIOGRAPHY AND FLUOROSCOPY 14 UNIEXPERT bright 15 UNIVERSAL RADIOGRAPHY SYSTEM FEATURING FLOOR STAND OR CEILING SUSPENSION AND MANUAL/MOTORIZED MOVEMENT џ The ability to customize the look џ Modular system џ Ergonomic design џ Improved experience with the device џ Confirm / reject image џ Generator parameter management џ Digital / analog technology џ Recoverable anti-scatter grid џ Obstacle protection system Acquisition console real time sync www.adanisystems.com RADIATION THERAPY 16 THERAD family 17 SUPERFICIAL ORTHOVOLTAGE SYSTEM џ Oncology, including veterinary џ Inflammatory diseases џ Neurology џ Rheumatology џ Orthopedy џ Dermatology џ Urology џ Gynecology џ Palliative care Applicator FSD, cm Tip, cm Cylindrical circular 20, 25, 30 0.5 - 10.0 Cylindrical elliptic 30 1.4 - 4.8 Cylindrical semilunar 30 1.0 - 3.2 Rectangular 30, 40, 50 4.0 - 20.0 100 200 300 Wide range of applicators keV keV keV www.adanisystems.com COMPUTED TOMOGRAPHY 18 VENTUM family 19 MULTISLICE COMPUTED X-RAY TOMOGRAPHY • High scanning speed • Feature customization • Powerful tools for 3D post-processing of CT-images, angiography and multiplanar reconstruction • Consultation and support with remote access available 16 32 64 128 Excellent image quality slices slices slices slices www.adanisystems.com DIGITAL DIAGNOSTIC RADIOLOGY FORENSIC SYSTEM 20 FOBOS XR 21 FORENSIC BODY SCANNER џ High-resolution radiographic image џ Embedded software package џ Picture archiving and communication system (PACS) compatibility џ DICOM 3.0 capability џ Oblique image projections (0 to 90° available, in increments of 1°) џ Available on 4K Ultra HD monitors up to 80" Mobile forensic solution available www.adanisystems.com ADANI (since 1991) is a world-class high-technology company of a full innovation cycle focused on disruptive innovation solutions for medical radiology, X-ray security screening, non-destructive testing, radiation control and ESR spectrometry. ADANI is manufacturing the unique model range of medical X-ray products like mammography and general radiography systems as well as mobile healthcare and radiotherapy units of different purpose. ADANI fully complies with ISO 9001 and ISO 13485 having CE and FDA confirmed products in portfolio..
Load more

Recommended publications
  • Breast Scintimammography
    CLINICAL MEDICAL POLICY Policy Name: Breast Scintimammography Policy Number: MP-105-MD-PA Responsible Department(s): Medical Management Provider Notice Date: 11/23/2020 Issue Date: 11/23/2020 Effective Date: 12/21/2020 Next Annual Review: 10/2021 Revision Date: 09/16/2020 Products: Gateway Health℠ Medicaid Application: All participating hospitals and providers Page Number(s): 1 of 5 DISCLAIMER Gateway Health℠ (Gateway) medical policy is intended to serve only as a general reference resource regarding coverage for the services described. This policy does not constitute medical advice and is not intended to govern or otherwise influence medical decisions. POLICY STATEMENT Gateway Health℠ does not provide coverage in the Company’s Medicaid products for breast scintimammography. The service is considered experimental and investigational in all applications, including but not limited to use as an adjunct to mammography or in staging the axillary lymph nodes. This policy is designed to address medical necessity guidelines that are appropriate for the majority of individuals with a particular disease, illness or condition. Each person’s unique clinical circumstances warrant individual consideration, based upon review of applicable medical records. (Current applicable Pennsylvania HealthChoices Agreement Section V. Program Requirements, B. Prior Authorization of Services, 1. General Prior Authorization Requirements.) Policy No. MP-105-MD-PA Page 1 of 5 DEFINITIONS Prior Authorization Review Panel – A panel of representatives from within the Pennsylvania Department of Human Services who have been assigned organizational responsibility for the review, approval and denial of all PH-MCO Prior Authorization policies and procedures. Scintimammography A noninvasive supplemental diagnostic testing technology that requires the use of radiopharmaceuticals in order to detect tissues within the breast that accumulate higher levels of radioactive tracer that emit gamma radiation.
    [Show full text]
  • Breast Imaging H
    BREAST IMAGING H. Lee Moffitt Cancer Center and Research Institute Rotation Director: Margaret Szabunio, M.D. General Goals : On this rotation, the resident will learn to interpret screening mammograms and to perform diagnostic mammography and ultrasound examinations of the breast. The resident will learn to formulate appropriate differential diagnoses and recommendations for various breast pathologies. The resident will also learn mammographic, ultrasound and MR breast biopsy techniques. Daily Work : The resident rotation begins after morning conference has concluded. In this rotation the resident shall learn BIRADS nomenclature and become proficient in using the PENRAD system for reporting. The resident will also learn the difference between screening and diagnostic mammography and how to perform a diagnostic work-up. (S)he will become familiarized with mammographic positioning and technique and quality assurance including MQSA and ACR requirements. The resident will learn to interpret mammographic images and the use of additional mammographic views for problem solving. (S)he will learn when and how to employ sonography in patient evaluation. The resident is REQUIRED to attend Thursday morning breast interdisciplinary conference. Preparing and reviewing cases for this conference is highly recommended. The resident will assist with and perform needle localizations, breast biopsy and cyst aspiration procedures using mammographic, stereotactic and sonographic techniques for each. The resident is expected to identify proper indications and contraindications for each procedure and how to identify and manage complications. The resident is expected to understand and complete informed consent for image guided breast procedures. On occasion, the resident may observe or assist with ductography procedures. Opportunity to observe and assist with MR guided breast procedures may also be available.
    [Show full text]
  • Fluoroscopy in Research Fact Sheet
    Fluoroscopy in FactSheet Research luoroscopy is an imaging procedure that uses a continuous x-ray beam to create real-time images viewed on a monitor. It enables physicians to view internal organs and vessels in motion and can be used in both F diagnostic and therapeutic procedures. The long term risk associated with fluoroscopy is cancer, What I need to know... however, more immediate risks of skin injury due to high doses are possible. The typical fluoroscopic entrance Dose Reduction Techniques exposure rate for a medium-sized adult is approximately 30 mGy/min (3 rad/min), but is typically higher in image- • Use ultrasound imaging when possible. recording modes. Table 1 on the next page illustrates skin • Position the image intensifier as close to the injury per fluoroscopy dose and time of onset. patient as practicable. • Maximize the distance from the radiation For physicians/researchers, it is not often clear when the source. use of fluoroscopy is considered Standard of Care versus research. • Remove Grids. Grids improve the image quality, however, they increase the dose to the Standard of Care (SOC) is about clinical judgement, patient and staff by a factor of two or more. decision flexibility, whereas research needs to adhere • Use pulsed rather than continuous fluoroscopy strictly to protocols. The following assessments assist when possible, and with as low a pulse as the physician/researcher in determining whether use of possible. fluoroscopy is for research purposes: • Would the subject receive this care absent of the clinical trial? • Can you back yourself up in the literature? • Does local SOC differ from national standards/ guidelines? • Are protocol deviations documented? For any “NO” answer to the above, use of fluoroscopy may be for research purposes.
    [Show full text]
  • Evaluation of Nipple Discharge
    New 2016 American College of Radiology ACR Appropriateness Criteria® Evaluation of Nipple Discharge Variant 1: Physiologic nipple discharge. Female of any age. Initial imaging examination. Radiologic Procedure Rating Comments RRL* Mammography diagnostic 1 See references [2,4-7]. ☢☢ Digital breast tomosynthesis diagnostic 1 See references [2,4-7]. ☢☢ US breast 1 See references [2,4-7]. O MRI breast without and with IV contrast 1 See references [2,4-7]. O MRI breast without IV contrast 1 See references [2,4-7]. O FDG-PEM 1 See references [2,4-7]. ☢☢☢☢ Sestamibi MBI 1 See references [2,4-7]. ☢☢☢ Ductography 1 See references [2,4-7]. ☢☢ Image-guided core biopsy breast 1 See references [2,4-7]. Varies Image-guided fine needle aspiration breast 1 Varies *Relative Rating Scale: 1,2,3 Usually not appropriate; 4,5,6 May be appropriate; 7,8,9 Usually appropriate Radiation Level Variant 2: Pathologic nipple discharge. Male or female 40 years of age or older. Initial imaging examination. Radiologic Procedure Rating Comments RRL* See references [3,6,8,10,13,14,16,25- Mammography diagnostic 9 29,32,34,42-44,71-73]. ☢☢ See references [3,6,8,10,13,14,16,25- Digital breast tomosynthesis diagnostic 9 29,32,34,42-44,71-73]. ☢☢ US is usually complementary to mammography. It can be an alternative to mammography if the patient had a recent US breast 9 mammogram or is pregnant. See O references [3,5,10,12,13,16,25,30,31,45- 49]. MRI breast without and with IV contrast 1 See references [3,8,23,24,35,46,51-55].
    [Show full text]
  • Upper Gastrointestinal Series
    Fluoroscopy-Upper Gastrointestinal (UGI) To Schedule: (319) 861-7778 Questions about Procedure: (319) 398-6050 What is an Upper Gastrointestinal (UGI) Series? A upper gastrointestinal (UGI) series refers to a x-ray of the upper digestive tract. This includes the esophagus and stomach and may include the small bowel, if requested by your physician. In order to visualize the upper digestive tract, you will be asked to swallow gas-producing granules. You will also be asked to drink some barium, and the radiologist or radiologist assistant will take images as the barium moves through your system. The esophagus or stomach procedures usually take about 30 minutes. If a small bowel study is also requested, the exam may take 2-4 hours with the extra time necessary to follow the barium through the small intestine. Preparation: Day 1 – Day Before Exam 1. You may eat or drink anything the day before the study until 10:00 pm. You are encouraged to drink plenty of fluids. 2. After 12:00 a.m. (midnight) do not eat or drink anything until your exam has been completed on the following day. 3. After 12:00 a.m. (midnight) do not smoke or chew gum until your exam has been completed on the following day. Day 2 – Day of Exam 1. No breakfast, do not eat or drink until after the test. 2. Take NO medications. PLEASE BRING THE FOLLOWING TO YOUR APPOINTMENT: A PHOTO ID TO VERIFY YOUR IDENTITY A LIST OF CURRENT MEDICATIONS YOU ARE TAKING Procedure: 1. You will be asked to drink a small glass of barium and to swallow some bubble-forming granules.
    [Show full text]
  • Breast Imaging Faqs
    Breast Imaging Frequently Asked Questions Update 2021 The following Q&As address Medicare guidelines on the reporting of breast imaging procedures. Private payer guidelines may vary from Medicare guidelines and from payer to payer; therefore, please be sure to check with your private payers on their specific breast imaging guidelines. Q: What differentiates a diagnostic from a screening mammography procedure? Medicare’s definitions of screening and diagnostic mammography, as noted in the Centers for Medicare and Medicaid’s (CMS’) National Coverage Determination database, and the American College of Radiology’s (ACR’s) definitions, as stated in the ACR Practice Parameter of Screening and Diagnostic Mammography, are provided as a means of differentiating diagnostic from screening mammography procedures. Although Medicare’s definitions are consistent with those from the ACR, the ACR's definitions of screening and diagnostic mammography offer additional insight into what may be included in these procedures. Please go to the CMS and ACR Web site links noted below for more in- depth information about these studies. Medicare Definitions (per the CMS National Coverage Determination for Mammograms 220.4) “A diagnostic mammogram is a radiologic procedure furnished to a man or woman with signs and symptoms of breast disease, or a personal history of breast cancer, or a personal history of biopsy - proven benign breast disease, and includes a physician's interpretation of the results of the procedure.” “A screening mammogram is a radiologic procedure furnished to a woman without signs or symptoms of breast disease, for the purpose of early detection of breast cancer, and includes a physician’s interpretation of the results of the procedure.
    [Show full text]
  • Interventional Fluoroscopy Reducing Radiation Risks for Patients and Staff
    NATIONAL CANCER INSTITUTE THE SOCIETY OF INTERVENTIONAL RADIOLOGY Interventional Fluoroscopy Reducing Radiation Risks for Patients and Staff Introduction CONTENTS Interventional fluoroscopy uses ionizing radiation to guide small instruments such as catheters through blood vessels or other pathways in the body. Interventional fluoroscopy represents a Introduction 1 tremendous advantage over invasive surgical procedures, because Increasing use and it requires only a very small incision, substantially reduces the complexity of risk of infection and allows for shorter recovery time compared interventional fluoroscopy 1 to surgical procedures. These interventions are used by a rapidly expanding number of health care providers in a wide range of Determinants of radiation medical specialties. However, many of these specialists have little dose from interventional fluoroscopy 2 training in radiation science or protection measures. The growing use and increasing complexity of these procedures Radiation risks from interventional fluoroscopy 3 have been accompanied by public health concerns resulting from the increasing radiation exposure to both patients and health care Strategies to optimize personnel. The rise in reported serious skin injuries and the radiation exposure from expected increase in late effects such as lens injuries and interventional fluoroscopy 4 cataracts, and possibly cancer, make clear the need for informa- Physician-patient tion on radiation risks and on strategies to control radiation communication before and exposures to patients and health care providers. This guide after interventional fluoroscopy 4 discusses the value of these interventions, the associated radiation risk and the importance of optimizing radiation dose. Dosimetry records and follow up 4 Education and training 5 Increasing use and complexity of interventional Conclusion 5 fluoroscopy Reference list 5 In 2002, an estimated 657,000 percutaneous transluminal coronary angioplasty (PTCA) procedures were performed in adults in the United States.
    [Show full text]
  • ACR Practice Parameter for Performance of Contrast Enhanced
    The American College of Radiology, with more than 30,000 members, is the principal organization of radiologists, radiation oncologists, and clinical medical physicists in the United States. The College is a nonprofit professional society whose primary purposes are to advance the science of radiology, improve radiologic services to the patient, study the socioeconomic aspects of the practice of radiology, and encourage continuing education for radiologists, radiation oncologists, medical physicists, and persons practicing in allied professional fields. The American College of Radiology will periodically define new practice parameters and technical standards for radiologic practice to help advance the science of radiology and to improve the quality of service to patients throughout the United States. Existing practice parameters and technical standards will be reviewed for revision or renewal, as appropriate, on their fifth anniversary or sooner, if indicated. Each practice parameter and technical standard, representing a policy statement by the College, has undergone a thorough consensus process in which it has been subjected to extensive review and approval. The practice parameters and technical standards recognize that the safe and effective use of diagnostic and therapeutic radiology requires specific training, skills, and techniques, as described in each document. Reproduction or modification of the published practice parameter and technical standard by those entities not providing these services is not authorized. Revised 2018 (Resolution 34)* ACR PRACTICE PARAMETER FOR THE PERFORMANCE OF CONTRAST- ENHANCED MAGNETIC RESONANCE IMAGING (MRI) OF THE BREAST PREAMBLE This document is an educational tool designed to assist practitioners in providing appropriate radiologic care for patients. Practice Parameters and Technical Standards are not inflexible rules or requirements of practice and are not intended, nor should they be used, to establish a legal standard of care1.
    [Show full text]
  • Pediatric Upper Gastrointestinal (GI) Series
    Pediatric Upper Gastrointestinal (GI) Series An upper gastrointestinal (GI) series is an x-ray exam of the upper digestive tract. This includes the mouth, esophagus, stomach, and duodenum (first part of the small intestine). The exam is used to detect problems such as strictures (narrowing), or ulcers (sores in the lining of the GI tract). Barium contrast or another kind of contrast material is used during the exam. This is a liquid that makes organs show more clearly on x-rays. During an upper GI series with small bowel follow-through, the doctor also checks the small intestine. An upper GI series takes about 60 minutes. An upper GI series with small bowel follow-through takes about 3 hours. Before the Exam Don’t give your child anything to eat or drink 4–6 hours before the exam. Follow all other instructions given by the doctor. Let the Technologist Know For your child’s safety, let the technologist know if your child: Has allergies. Has any health problems. Has had surgery. Is taking any medications. During an upper GI series, your child is given liquid barium contrast to drink. During the Exam An upper GI series is performed by a radiologist. This is a doctor trained to use x-rays to test or treat patients. A radiology technologist may also assist with the exam. You can stay with your child in the x-ray room. You’ll be given a lead apron to wear for your safety. Your child stands against the x-ray table during the first part of the exam.
    [Show full text]
  • Diagnostic and Nuclear Medical Physics Residency Program Summary of Rotation Presentation Topics
    Diagnostic and Nuclear Medical Physics Residency Program Summary of Rotation Presentation Topics Last updated: 11/17/2020 Radiography (2020) Advanced image processing in digital radiography (2020) Dual energy x-ray absorptiometry (DXA) (2019) EOS scoliosis imaging system (2019) Dental radiographic technologies (2018) Radiographic techniques for scoliosis patients (2018) Exposure index in digital radiography (2017) Heel effect and how to mitigate it in clinical procedures, physics testing and image processing (2017) AAPM TG 151: ongoing quality control in digital radiography (2016) Routine applications, special procedures, and QC for projection radiography Fluoroscopy (2020) Fluoroscopy-guided trans-catheter aortic valve replacement (TAVR) (2020) The process of estimating peak skin dose (PSD) in fluoroscopy (2019) My clinical observations of non-interventional fluoroscopy procedures (2019) Medical physics guide to calculating peak skin dose from RDSR data (2018) My shadowing experience in non-interventional fluoroscopy (2018) Interventional fluoroscopy in cardiology (2017) Patient skin dose estimation in fluoroscopic procedures (2017) TheraSphere® Yttrium-90 microsphere therapy (2016) Clinical applications and methods to monitor and reduce patient dose in fluoroscopy Mammography (2020) Mammography screening recommendations and data (2020) Medical physicist’s tests in the 2018 ACR digital mammography QC manual (2019) Contrast-enhanced digital mammography and tomosynthesis-guided biopsies (2019) Technology improvements
    [Show full text]
  • Icd-9-Cm (2010)
    ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular
    [Show full text]
  • WHO Position Paper on Mammography Screening
    Introduction Mammography is an X-ray of the breast to identify malignant changes. It is used both as a diagnostic tool to examine symptomatic women and as a screening test in asymptomatic women. The goal of screening mammography is to detect breast cancer early, prior to feeling a breast lump; while ensuring consistently high quality mammography results with minimal exposure of the women to radiation. The success of mammography screening depends not only on the quality performance of the technology, but on having an organized population based screening program, that achieves high screening coverage of women in the at risk age group, followed by diagnosis and treatment for women detected with abnormal results. Key Questions 1.WHAT ARE THE MAMMOGRAPHY SCREENING RECOMMENDATIONS? In well-resourced settings, organized population-based mammography screening programs are recommended for women aged 50-69 years, every 2 years. In these settings, screening programs for women 40- 49 years of age and 70-75 years of age is suggested only if it is conducted in the context of rigorous research, monitoring and evaluation. In limited resource settings with relatively strong health systems, organized population-based mammography screening programs are suggested for women aged 50-69 years, every 2 years only if the conditions for implementing a screening program are met. In these settings, WHO recommends against mammography screening for women 40-49 years of age and 70-75 years of age. In limited resource settings with weak health systems, organized population-based mammography screening programs may not be cost-effective and feasible. Early diagnosis of symptomatic women with prompt diagnosis and treatment should be the priority.
    [Show full text]